Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.
|ClinicalTrials.gov Identifier: NCT00249730|
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : December 19, 2006
|Condition or disease||Intervention/treatment||Phase|
|Impotence||Drug: Sildenafil||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||510 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Prospective Multicenter, Parallel Group Study With A Single Blind Phase And A Double Blind Randomised Phase, To Evaluate The Efficacy And Satisfaction Of Viagra (Sildenafil Citrate) High Dose (100mg) Titration Compared With 50mg Dose, In Men With Erectile Dysfunction|
|Study Start Date :||October 2005|
- Change in IIEF erectile function domain score at the end of double blind treatment.
- Change in other IIEF domain scores; Response to other questionnaires regarding treatment satisfaction, safety and tolerability.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00249730
Show 39 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|